ArticleBMC geriatrics2025
Assessing the quality of life in patients with complex chronic conditions: Cronimad study.
Article in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPeople's life expectancy has increased significantly in the past few decades, which has been associated with an increased prevalence of chronic diseases. Chronic-complex patients (CCP), including those characterized as polypathological patients (PPP), are now the majority among chronic patients and are considered a priority group in healthcare settings. This study aimed to determine the health-related quality of life (QoL) of Spanish CCP and its association with sociodemographic, clinical and functional variables and cognitive status.
methodsPatients identified as CCP or PPP from six hospitals in the Community of Madrid were included. The primary endpoint was to determine the QoL of CCP/PPP. To do so, patients were asked to complete the EuroQol questionnaire that included the visual analog scale (EQ-VAS), and the questionnaire with 5 dimensions and 5 levels (EQ-5D-5 L). Several socio-demographic/health-related variables were further evaluated and correlated with QoL.
resultsA total of 128 CCP/PPP were included. A median EQ-VAS score of 60.0 [45.0, 80.0, and 0.64 [0.40, 0.79] on the EQ-5D-5 L Index were observed. Moderate to severe pain, functional impairment, gait disorders, and malnutrition were independently associated with poorer QoL when using the EQ-5D-5 L scale, and with the last two variables (gait disorders and malnutrition) when using the EQ-VAS scale.
conclusionThe present study highlights the need for better strategies to qualify and validate the QoL in this specific group of patients. Given the small sample of respondents, the present findings should be considered preliminary and only for hypothesis generation. Nevertheless, it further sheds some light on the different factors that should be considered, not only to stratify patients at varying levels of QoL but also to modulate the life quality of CCP/PPP in daily care setting.
trial registrationNot applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.